Tumor-secreted PCSK9 promotes intratumoral accumulation of cholesterol[225], prevents LDLR and TCR recycling in CD8+ TILs[226], and inhibits MCH-1 recycling on tumor cells[227], leading to immune evasion in multiple ways. Here, LDLR is linked to neoplasm.